• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Biological uncertainties in proton therapy for paediatric mediastinal Hodgkin Lymphoma

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Aznar, Marianne Camille
    Rechner, L. A.
    Maraldo, M. V.
    Smith, E
    Lundgaard, A.
    Hjalgrim, L. L.
    Safwat, A.
    Mackay, Ranald I
    Aitkenhead, Adam H
    Affiliation
    The University of Manchester, Division of Cancer Sciences, Manchester,
    Issue Date
    2020
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective Proton Beam Therapy (PBT) is associated with different types of uncertainties than photon therapy. For example, it is unknown how much the increase in linear energy transfer (LET) and relative biological effectiveness (RBE) at the end of a proton’s range impact the doses to organs at risk (OARs). For paediatric patients with mediastinal Hodgkin lymphoma (HL), increased LET at the distal edge of the beam could, in theory, result in “hot spots” in the heart, oesophagus or lungs. Here, we investigate the impact of different beam arrangements on the LET distribution and dose to mediastinal OARs. In addition, we explore the impact of using a variable RBE in the dose calculation. Material and Methods Three paediatric patients with mediastinal HL previously treated with photon-based radiotherapy were selected for this study (ages 14-16 clinical stage 2A, one with bulky disease). We retrospectively created proton plans for each patient with 1 (anterior-posterior (AP)), 2 (APoblique), and 3 (AP-oblique and posterior-anterior) beams for a Varian Probeam delivery system, using a commercial treatment planning system (TPS, Eclipse v13.7). The prescription dose was 19.8 Gy (RBE) in 11 fractions. Beam arrangements were selected to reflect current clinical practice for paediatric HL treatments. Robust optimisation to the CTV, assuming an uncertainty of 3.5% in CT calibration and 5 mm in positioning was used. Single field uniform dose optimisation was used as a default and plans were optimised for a fixed RBE of 1.1. All plans were exported and recalculated with AUTOMC, an in-house Monte Carlo (MC) software based on GATE v8.1 and GEANT4 v10.3.3 (GATE RTion). Dose-averaged LET was scored and variable RBE dose was calculated using the McNamara model with an alpha/beta ratio of 2. Doses to the heart, cardiac sub-structures, lungs, breasts, oesophagus and spinal cord were recorded. A “hot spot” was defined as an overlap of regions receiving ≥ 80% prescription dose and regions with high LET (≥6 keV/μm). Results All treatment plans had acceptable target coverage and robustness (evaluated with TPS dose). Dose differences between all strategies (TPS with fixed RBE, MC with fixed RBE and MC with variable RBE) were small (see figure 1). LET generally decreased as the number of beams increased. No “hot spot” was observed in plans using > 1 field. However, 2 plans using a 1-field arrangements revealed small “hot spots“ of 0.004 cc in muscle (Patient 1), or 0.11 cc located in the vertebra, carina, and descending aorta (Patient 3). The use of MC had a larger influence on the dose distribution than the use of a variable RBE (see figure 2). Conclusion In this study, increased LET and RBE at the end of proton range did not result in clinically meaningful hot-spots to OARs for paediatric patients with mediastinal HL, regardless of the beam arrangement. However, uncertainties remain in models of variable RBE, and further studies are needed to confirm these results.
    Citation
    Aznar M, Rechner LA, Maraldo MV, Smith E, Lundgaard A, Hjalgrim LL, et al. PD-0302: Biological uncertainties in proton therapy for paediatric mediastinal Hodgkin Lymphoma. Radiotherapy and Oncology . 2020 Nov;152:S155–6. 
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/624151
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.